Salute e Benessere

Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in…

The CUPID (64CuPSMA Imaging and (Bio) Distribution) study is a 3+3 mass dose escalation study with four patient cohorts intended to evaluate the safety, tolerability, pharmacokinetics, biodistribution and radiation dosimetry of TLX592. The study utilises copper-64 (64Cu) which is detectable by Positron Emission Tomography (PET) as a surrogate for actinium-225 (225Ac), enabling a successful proof-of-targeting study as well as predictive dosimetry calculations for future studies with 225Ac…
PR Newswire
21/05/2024

NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)

Right to participate and notice of participation Right to participate and notice of participation A shareholder who wishes to participate in the AGM must (i) be registered in the share register kept by Euroclear Sweden AB as of Tuesday11 June 2024, and (ii) notify its intention to participate in the AGM no later than Thursday13 June 2024, either by post to "Bolagsstämma", Immunovia AB, Scheelevägen 8, SE-223 63Lund, Sweden, or via email tobolagsstamma@immunovia.com. The...
PR Newswire
21/05/2024

Immunovia carries out a rights issue of units of approximately SEK 70 million…

Summary Summary • The Rights Issue includes units and will initially, if fully subscribed, provide Immunovia with approximatelySEK 70 millionbefore issue costs. Each unit consists of two (2) shares, two (2) warrants series TO 2 and one (1) warrant series TO 3. The warrants are intended to be admitted to trading on Nasdaq Stockholm. • One (1) warrant series TO 2 entitles the holder to subscription of one (1) share in the Company during the period from and including2 January...
PR Newswire
21/05/2024

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,529,599,938 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
20/05/2024

Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD…

Dupixent ®late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammationData support the potential of Dupixent as the first new treatment approach in more than a decade...
Nasdaq GlobeNewswire
20/05/2024

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to…

"The maintenance of the current authorization of Translarna is a big win for boys and young men with nonsense mutation Duchenne muscular dystrophy in Europe," said Matthew B. Klein, M.D., Chief Executive Officer, PTC Therapeutics. "The efficacy and safety demonstrated in clinical trials and the long-term STRIDE registry support that Translarna fills an otherwise unmet need for nmDMD patients. We look forward to working collaboratively with CHMP on next steps once they are…
PR Newswire
20/05/2024

Nature Medicine Highlights Significant Improvement in Hand and Arm Function…

ARC Therapy™ shown to be safe and effective in global pivotal trial* 90% of participants improved either strength or function of upper limbs*Improvement demonstrated in participants up to 34 years post-injury*87% of participants also reported improvement in overall quality of life* EINDHOVEN, the Netherlands, May20, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
Nasdaq GlobeNewswire
20/05/2024

Inside information: Alan Donze has been appointed as Bioretec's new CEO

Mr. Donze began his career journey in the banking industry, serving as the Vice President of Commercial Lending and Leveraged Finance for a regional predecessor to Chase bank. He left banking to begin his medical device career as a Regional Sales Representative for Stryker Endoscopy in 1991. Over his 13 years at Stryker, Mr. Donze's responsibilities increased to various senior management positions, including Vice President General Manager of Stryker Endoscopic Service and Vice President General…
PR Newswire
20/05/2024

Life Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive…

Life sciences encompass a wide range of fields, including biology, biochemistry, genetics, pharmacology, and many more. Laboratory equipment plays a critical role in conducting experiments, collecting data, and analyzing samples to further scientific research and advance our understanding of living organisms and their underlying mechanisms. Equipment is also necessary for quality checks and validation of manufactured drugs and biologics in the life sciences industry. The growth of the life…
PR Newswire
20/05/2024

Electrosurgery Market Worth $9.4 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761 Browse in-depth TOC on "Electrosurgery Market" 268 - Tables60 - Figures320 - Pages Electrosurgery Market Scope: "Electrosurgical instruments are projected to experience the most rapid expansion within the electrosurgery market throughout the forecast period...
PR Newswire
20/05/2024

Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of…

For more information, visit www.pierre-fabre.com, @PierreFabreGroup. For more information, visit www.pierre-fabre.com , @PierreFabreGroup . Pierre Fabre Laboratories Media Contact: Laurence Marchal, Laurence.marchal@pierre-fabre.com PDF -https://mma.prnewswire.com/media/2416807/Pierre_Fabre_PDF.pdfLogo -https://mma.prnewswire.com/media/2416854/Pierre_Fabre_Laboratories.jpg View original content to download multimedia:...
PR Newswire
20/05/2024

EuroPCR: Medtronic Evolut™ TAVR Platform Demonstrates Improved Quality of Life…

Symptomatic severe AS can be fatal if left untreated and the average patient survival is two years without treatment.1 Despite women's longer life expectancy, once impacted by severe AS they suffer from higher mortality than men, even after matching for age.2 Both TAVR and surgical aortic valve replacement (SAVR) are options for women to treat AS. However, due to their smaller aortic annuli, women can often receive a valve replacement that does not properly fit their anatomy.3 Symptomatic...
PR Newswire
20/05/2024

Hisense Welcomes Goalkeeping Icon Iker Casillas to UEFA EURO 2024™ 'BEYOND…

"I am delighted to partner with Hisense and join the 'BEYOND GLORY' campaign which puts the spotlight on celebrating the world's best goalkeepers," explained Iker Casillas. "A goalkeeper's winning reputation is based on their reliability. I am pleased to be invited by Hisense as a Global Ambassador, representing a company relied on by its customers for creating innovative technology that improves their lives." "I am delighted to partner with Hisense and join the 'BEYOND…
PR Newswire
20/05/2024

Cresilon Announces International Distribution Agreement for VETIGEL with…

Based in the UK, Vi is part of the Covetrus animal health family of worldwide businesses. Cresilon's VETIGEL, a plant-based haemostatic gel that instantly stops and controls bleeding, is available online for UK veterinary surgeons through Vi's extensive portfolio of surgical and orthopaedic instrumentation, joint surgery, and fracture fixation products. Based in the UK, Vi is part of the Covetrus animal health family of worldwide businesses. Cresilon's VETIGEL, a plant-based haemostatic gel...
PR Newswire
20/05/2024

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT…

"We are excited to present the data to the scientific community at the IAPRD for the first time. Pioneering work in the 1990s using human fetal midbrain has already demonstrated that cell therapy can bring real clinical benefits to patients [5] and, in the last decade, an increasing number of trials have been launched using pluripotent stem cells as a more standardizable cell source." says Jens Schroeder, Chief Medical Officer, TreeFrog Therapeutics. "Cell therapy has the…
PR Newswire
20/05/2024

Pharming Group to participate in May investor conference

Leiden, the Netherlands, May 20, 2024:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conference in the month of May: H.C. Wainwright 2 ndAnnual BioConnect Investor Conference at NASDAQ, New York, May 20, 2024Michael Levitan, VP Investor Relations and Corporate Communications will present on Monday, May 20 at 09:30 EDT/15:30 CET.For more information about this...
Nasdaq GlobeNewswire
20/05/2024

Subang Jaya Medical Centre Applauded by Frost & Sullivan as the Best Hospital…

The company is a private hospital with 443 licensed beds and over 150 outpatient clinics. It handles approximately 50,000 admissions and 550,000 outpatient visits annually. With a workforce of around 1,600 healthcare professionals, SJMC offers services across more than 260 medical specialties encompassing diverse therapeutic areas such as oncology, cardiology, orthopedics, digestive health as well as women and children health. The company is a private hospital with 443 licensed beds and over...
PR Newswire
20/05/2024

More than $9 Million Awarded to High School Scientists and Engineers at the…

The top winners were honored during two award ceremonies: the Special Awards on May 16 and the Grand Awards Ceremony on the morning of May 17. In total, over $9 million USD was awarded to the finalists based on their projects' creativity, innovation and depth of scientific inquiry. The competition featured nearly 2,000 young scientists representing 49 U.S. states and nearly 70 countries, regions and territories across the world. The top winners were honored during two award ceremonies: the...
PR Newswire
17/05/2024

DBV Technologies Announces Plan to Implement ADS Ratio Change

DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”), nominal value €0.10 (ten cents) per share,...
Nasdaq GlobeNewswire
17/05/2024

Oculis updates share capital for its existing at-the-market offering program

The New Shares were issued following the Company and Leerink Partners LLC (”Leerink Partners”) entering into a sales agreement (the "Sales Agreement") with respect to an at-the-market offering program on May 8, 2024 under which the Company may offer and sell, from time to time at its sole discretion, ordinary shares of the Company having an aggregate offering price of up to $100 million through Leerink Partners as its sales agent. The Company is not obligated to make any sales of…
Nasdaq GlobeNewswire
17/05/2024

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al…

In partnership with the Department of Health – Abu Dhabi (DoH), the Summit took place on May 14-15, 2024 at Cleveland Clinic Abu Dhabi and showcased the 11 innovative finalists, as well as highlighted existing innovators and opportunities in the Emirate of Abu Dhabi. The event also featured keynote speeches from Dr. Laurie Glimcher of Dana-Farber Cancer Institute, Dr. Shahrukh Hashmi of the Department of Health – Abu Dhabi, and Dr. David Ho of Columbia University Medical Center and provided…
PR Newswire
17/05/2024

Smart Bathroom Market Size to Grow USD 2709.1 Million by 2030 at a CAGR of 7.4%…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-33B2244/Global_Smart_Bathroom Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-33B2244/Global_Smart_Bathroom Major Factors Driving the Growth of Smart Bathroom Market: Due to their improved user experience, cost-effectiveness, and hygiene, smart toilets in commercial settings are a major factor in the market's expansion. Smart toilets featuring touchless flush systems, automatic cleaning,...
PR Newswire
17/05/2024

Collagen Water Market Worth USD 6.9 Billion by 2031 - Exclusive Report by…

Download Free Report Sample Pages @ https://www.insightaceanalytic.com/request-sample/2478 Download Free Report Sample Pages @ https://www.insightaceanalytic.com/request-sample/2478 Collage water is water that has collagen peptides added to it. Collagen is an animal-derived protein that is present in connective tissues, skin, and bones. The collagen in this water is absorbed practically, and there can be health benefits to that. The market is growing because the cosmetics and...
PR Newswire
17/05/2024

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting…

MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE)— BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the virtual assembly. There were 14 items on the agenda of the AGM. All resolutions proposed on the agenda items put to the vote at today's AGM were approved by a large majority of the shareholders.“The past few years marked a leap in competence for...
Nasdaq GlobeNewswire
17/05/2024
Altri  Comunicati